Gil, Emilio; García-Alonso, Fernando; Boldeanu, Anca; Teixeira, Thais-Baleeiro; Tordera, Vicente; Palmer-Viciedo, Ramon; Salgado, Purificacion; Domingo-Ribas, Jordi; Corripio-Collado, Iluminada; Montes, José-Manuel; Correas-Lauffer, Javier; Ruiz-Murugarrem, Salvador; Ovejero-García, Santiago; Mora, Fernando; López, Ataz; Fontalba-Navas, Andrés; González-Pinto, Ana-María; Martínez, Ricardo; García-Castrillo, César; Toledo, Francisco; Vieta, Eduard; González, Emilio; Franco, Manuel; Virgil-Drasovean, Nicolae; Havard-Dahl, Nils; Skagen, Bo; Zilles, David; Zwanzger, Peter; Juckel, Georg; Kahl, Kai-G; Messer, Thomas; Kasper, Siegfried
(BMJ PUBLISHING GROUP, 2018-10)
INTRODUCTION: There is a need for fast-acting, non-injection antiagitation treatments that are well tolerated and can be used outside of healthcare facilities. In phase II/III trials, an inhaled formulation of loxapine ...